Drug Manufacturers Must Submit Annual Disclosure Reports to the Minnesota Board of Pharmacy by May 1, 2021

April 16, 2021

California Requires Pharmaceutical and Medical Device Manufacturers to Annually Declare Compliance with Their Comprehensive Compliance Program

April 14, 2021

North Carolina Introduces The Prescription Drug Transparency Act

April 09, 2021

Open Payments Review and Dispute Period for Physicians and Teaching Hospitals is Available Through May 15, 2021

April 02, 2021

Manufacturers and Wholesalers That Sell or Market Products in Nevada Must Submit Certification and Compliance Forms to the Nevada Board of Pharmacy by June 1, 2021

March 31, 2021

Certain Pharmaceutical Sales Reps Are Required to Obtain a License Prior to Conducting Business in Chicago, Illinois

March 26, 2021

Nevada Has Introduced Legislation That Would Require Licensure of Pharmaceutical Sales Representatives

March 22, 2021

Registered Client Lobbyists in Connecticut Must File Their Quarterly Financial Reports with the Office of State Ethics by April 10, 2021

March 19, 2021

Wisconsin Introduces Legislation That Would Require Pharmaceutical Representatives to Obtain a License

March 18, 2021

Prescription Drug, Biological Product, and Medical Device Manufacturers Must Submit Their Disclosure Reports to the Vermont Attorney General's Office by April 1, 2021

March 15, 2021

Oregon Introduces Legislation That Would Require Pharmaceutical Representatives to Obtain a License

March 12, 2021

Minnesota Board of Pharmacy Has Posted the 2020 Payments to Practitioners Reporting Form; Reports are Due May 1, 2021

March 10, 2021

Centers for Medicare and Medicaid Services Will Hold Open Payments Question and Answer Session on March 10, 2021

March 09, 2021

Centers for Medicare and Medicaid Services Issued an Updated Open Payments User Guide for Reporting Entities

March 08, 2021

Michigan Introduces Gift Prohibition Legislation

March 05, 2021

Federal Drug Samples Disclosure Reports for Calendar Year 2020 Are Due April 1, 2021; Companies Must Have FDA Electronic Submissions Gateway Account to Submit

February 19, 2021

Nevada Department of Health and Human Services Has Published the 2021 Essential Drug List; Manufacturer Reports are Due April 1, 2021

February 09, 2021

Centers for Medicare and Medicaid Services Will Hold Open Payments Webinar on February 10, 2021

February 05, 2021

Nevada Pharmaceutical Sales Representative Annual Disclosure Reports Due by March 1, 2021

February 03, 2021

Centers for Medicare and Medicaid Services Announces That the Open Payments System is Available for Program Year 2020 Data Submission; Entities Must Register or Recertify Registration

February 02, 2021

Federal Sunshine Payments Eligible for Delayed Publication Must Have the Delay Indicator Renewed in Each Applicable Program Year

January 27, 2021

The Centers for Medicare and Medicaid Services Has Published Open Payments Program Year 2019 Data Refresh

January 26, 2021

Louisiana Lobbyist Annual Registration Renewal Period for Calendar Year 2021 Ends January 31, 2021

January 21, 2021

Reporting Entities Registered in Open Payments Must Recertify Before Submitting Data for Upcoming Reporting Period; System Unavailable January 22-29, 2021

January 14, 2021

Senators Grassley and Wyden Provide Update on Opioid Manufacturers Financial Relationships Investigation; Recommend Open Payments Revision

January 12, 2021

Open Payments Expanded Covered Recipient Definition Now in Effect

January 06, 2021

Miami-Dade County, Florida Registered Lobbyists Must Submit Annual Renewal by January 15, 2021

December 30, 2020

REMINDER: Pharmaceutical Manufacturers Must Submit their Annual Nevada Sales Representative Registration by January 15, 2021

December 29, 2020

Vermont 2020 Compliance Officer Form and Annual Registration Fee Must be Submitted by January 1, 2021

December 23, 2020

Accreditation Council for Continuing Medical Education Has Released New Standards for Integrity and Independence in Accredited Continuing Education

December 15, 2020

Connecticut Lobbyist Registrations are Due by January 15, 2021

December 09, 2020

REMINDER: Open Payments Webinar to Discuss Expanded Open Payments Reporting Requirements is December 16, 2020

December 04, 2020

Miami-Dade County, Florida Registered Lobbyists Must Submit Annual Renewal by January 15, 2021

December 02, 2020

Centers for Medicare & Medicaid Services Announces Webinar to Discuss Expanded Open Payments Reporting Requirements

December 01, 2020

HHS-OIG Focuses on Speaker Programs with Special Fraud Alert

November 23, 2020

Open Payments Program Year 2021 Validated Physician List and Preliminary Non-Physician Practitioner List Now Available

November 20, 2020

Nevada Department of Health and Human Services Will Hold Public Workshop to Discuss Drug Price Transparency Program Rule Change

November 19, 2020

Pharmaceutical Manufacturers Must Submit their Annual Nevada Sales Representative Registration by January 15, 2021

November 16, 2020

Centers for Medicare and Medicaid Services Will Publish Open Payments Data Refresh in January 2021; Manufacturers Must Make Corrections By November 15, 2020

November 06, 2020

Device Company Settles Open Payment Program Reporting Violation, Agrees to Pay Over $9.2 Million

November 03, 2020

The Vermont Attorney General's Office Has Posted the 2020 Expenditure and Samples Disclosure Forms for Reporting Under the Prescribed Products Gift Ban and Disclosure Law

November 02, 2020

Louisiana Lobbyist Annual Registration Renewal Period for Calendar Year 2021 Begins December 1, 2020

October 29, 2020

Vermont Attorney General's Office Has Posted the 2020 Compliance Officer Form

October 22, 2020

Centers for Medicare and Medicaid Services Issued an Updated Open Payments User Guide for Reporting Entities

October 15, 2020

Centers for Medicare and Medicaid Services Has Published Teaching Hospital and Physician and Non-Physician Practitioner Taxonomy Lists for Program Year 2021

October 02, 2020

The Centers for Medicare and Medicaid Services has Published the Adjusted Federal Open Payments Reporting Thresholds for Program Year 2021

October 01, 2020

REMINDER: Massachusetts Pharmaceutical and Medical Device Manufacturer Annual Registration Renewal is Required by October 1, 2020

September 16, 2020

California Quarterly Wholesale Acquisition Cost Increase Report is Due by October 31, 2020

September 11, 2020

Nevada Department of Health and Human Services Proposes Amendments to Drug Transparency Program Regulations

August 31, 2020

The Centers for Medicare and Medicaid Services Has Posted Resources to Assist with Open Payments Expansion Reporting

August 24, 2020

REMINDER: Kentucky Executive Branch Extends Annual Lobbyist Registration Deadline to August 31 Due to COVID-19

August 18, 2020

French Sunshine Act Reporting Deadline Approaching

August 17, 2020

U.S. House of Representatives Introduces Legislation to Require Licensure of Sales Representatives Who Market Opioids

August 13, 2020

REMINDER: Massachusetts Department of Public Health Extends Pharmaceutical and Medical Device Manufacturer Registration Renewal Deadline in Response to COVID-19 Pandemic

August 11, 2020

AdvaMed Provides Guidance for COVID-19 Response

August 10, 2020

Centers for Medicare and Medicaid Services Open Payments Program Expansion Will Go Into Effect January 1, 2021

August 04, 2020

Michigan Has Introduced Legislation to Prohibit Manufacturers from Giving Gifts to Prescribers

August 03, 2020

PhRMA Issues "Statement of Application of PhRMA Code Section 2 During Emergency Periods"

July 31, 2020

The Centers for Medicare and Medicaid Services Has Posted Resources to Assist with Device Reporting on Its Open Payments Website

July 30, 2020

Nevada Department of Health and Human Services Issues 2020 Essential Drugs Transparency Report

July 10, 2020

Massachusetts Department of Public Health Extends Pharmaceutical and Medical Device Manufacturer Registration Renewal Deadline in Response to COVID-19 Pandemic

July 09, 2020

The Centers for Medicare and Medicaid Services Has Published Program Year 2019 Open Payments Data

July 08, 2020

Pennsylvania Has Introduced Legislation to Prohibit Manufacturers from Giving Gifts to Health Care Providers

July 07, 2020

REMINDER: Massachusetts Annual Disclosure Reports Due July 1, 2020

June 18, 2020

REMINDER: Applicable Manufacturers Must Submit Reports of Payments or Other Transfers of Value to APRNs Engaged in Independent Practice in Connecticut by July 1, 2020

June 16, 2020

District of Columbia Adopts Rule Change for Pharmaceutical Detailer Continuing Education Requirements

June 15, 2020

District of Columbia Prescription Drug Marketing Cost Reports Due July 1, 2020; COVID-19 Guidance Issued

June 05, 2020

REMINDER: Registered Lobbyists in Miami-Dade County, Florida Must Submit Annual Expenditure Report to the Board of County Commissioners by July 1, 2020

June 03, 2020

Pharmaceutical and Medical Device Manufacturers May Renew Registration With the Massachusetts Department of Public Health Beginning July 5, 2020

June 02, 2020

Connecticut Office of State Ethics Has Extended Lobbyist Financial Report Deadline to July 10, 2020, Due to COVID-19

May 29, 2020

The Open Payments Data Correction Period Began May 16, 2020, and Will End on May 30, 2020

May 20, 2020

Reminder: Open Payments Review and Dispute Period for Physicians and Teaching Hospitals Will End on May 15, 2020

May 13, 2020

REMINDER: Manufacturers and Wholesalers That Sell or Market Products in Nevada Must Submit Certification and Compliance Forms to the Nevada Board of Pharmacy by June 1, 2020

May 07, 2020

Massachusetts Department of Public Health Launches Pharmaceutical Code Of Conduct – Data and Reports Webpage; Annual Disclosure Reports Due July 1, 2020

May 06, 2020

Certain Pharmaceutical Sales Representatives Are Required to Obtain a License Prior to Conducting Business in Chicago, Illinois

May 05, 2020

The District of Columbia Department of Health has Posted the 2019 Prescription Drug Marketing Cost Reporting Form on Its Website; Reports are Due July 1, 2020

April 28, 2020

Applicable Manufacturers Must Submit Their Reports of Payments or Other Transfers of Value to APRNs Engaged in Independent Practice in Connecticut by July 1, 2020

April 22, 2020

Registered Lobbyists in Miami-Dade County, Florida Must Submit Their Annual Lobbyist Expenditure Report to the Board of County Commissioners by July 1, 2020

April 21, 2020

California Requires Pharmaceutical and Medical Device Manufacturers to Annually Declare Compliance with Their Comprehensive Compliance Program

April 20, 2020

Manufacturers and Wholesalers That Sell or Market Products in Nevada Must Submit Certification and Compliance Forms to the Nevada Board of Pharmacy by June 1, 2020

April 16, 2020

CMS Open Payments Annual Report to Congress for Program Year 2018 Shows Increase in Total Dollar Value of Reported Payments

April 14, 2020

The Open Payments Review and Dispute Period for Physicians and Teaching Hospitals is April 1, 2020, Through May 15, 2020

April 06, 2020

REMINDER - The Centers for Medicare and Medicaid Services Will Host an Open Payments Q&A Session Tomorrow, Thursday, March 26, 2020

March 25, 2020

Maine Adopts Regulations to Implement Prohibition on Gifts to Practitioners; Modest Meals, Reasonable Honoraria are Defined

March 23, 2020

Utah Has Introduced Legislation Requiring Manufacturers to Provide a List of Pharmaceutical Sales Representatives; Establishes Reporting and Price Disclosure Requirements

March 19, 2020

Prescription Drug, Biological Product, and Medical Device Manufacturers Must Submit Their Disclosure Reports to the Vermont Attorney General's Office by April 1, 2020; 2019 Guide to Disclosure Law is Available

March 16, 2020

The Centers for Medicare and Medicaid Services Has Posted Updated Quick Reference Guides and Overview for the 2019 Program Year

March 12, 2020

The Centers for Medicare and Medicaid Services Will Host an Open Payments Q&A Session on Thursday, March 26, 2020

March 05, 2020

The Minnesota Board of Pharmacy Has Posted the 2019 Payments to Practitioners Reporting Form; Reports are Due May 1, 2020

March 02, 2020

Nevada Department of Health and Human Services Has Published the 2020 Essential Drug List; Manufacturer Reports are Due April 1, 2020

February 28, 2020

Federal Drug Samples Disclosure Reports for Calendar Year 2019 Are Due April 1, 2020; Companies Must Have FDA Electronic Submissions Gateway Account to Submit

February 19, 2020

Federal Sunshine Payments Eligible for Delayed Publication Must Have the Delay Indicator Renewed in Each Applicable Program Year

February 14, 2020

Nevada Department of Health and Human Services Will Accept Pharmaceutical Representative Annual Disclosure Reports on Monday, March 2, 2020

February 13, 2020

The Centers for Medicare and Medicaid Services Will Hold Open Payments Webinar Session on February 18, 2020

February 10, 2020

CMS Announces That Applicable Manufacturers and GPOs May Begin Data Submission for Payments or Transfers of Value That Occurred in the 2019 Calendar Year; Entities Must Register or Recertify Registration

February 06, 2020

French Sunshine Act Reporting Deadline Approaching

February 04, 2020

Hawaii Introduces Legislation to Require Pharmaceutical Representatives to Register; Disclose Certain Activities; Abide by Ethical Standards

February 03, 2020

The Centers for Medicare and Medicaid Services Has Published an Open Payments Data Refresh

January 27, 2020

REMINDER: Prescription Drug Manufacturers Must Submit Their Annual Nevada Sales Representative List by January 15, 2020

January 02, 2020